Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Oracle facing growth acceleration acid test

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
‘Magnificent Seven’ earnings are behind us and Oracle (ORCL:NASDAQ) is one of just a handful of S&P 500 stocks still to report. There could be fireworks when it does on 9 September.
While AI (artificial intelligence) excitement dominates the headlines Oracle has been quietly going about its own AI transformation, with vigorous expansion into cloud services a strategic move that provides customers with lots of options. Avid Premier League fans will be familiar with match data powered by Oracle Cloud, for example.
The transition from traditional licencing to cloud-based subscription services is expected to fuel accelerated sales growth for Oracle and continue the rapid rise of the shares, which are up 35% this year alone.
Crucial to keeping markets onside will be evidence that Oracle’s profitability is becoming more powerful, which should be aided by the full integration of health tech firm Cerner, bought for $28 billion in 2022. Oracle has also made considerable efforts to cut out excess cost.
This anticipated improvement in profitability is seen as a key factor that could influence the company's financial performance positively. Analysts at Edward Jones recently suggested that the current $141.29 share price may not fully reflect the firm’s optimism for sales growth acceleration.
This is the acid test, and recent quarterlies have left investors a bit underwhelmed, with mild forecast misses in June’s fourth quarter update.
US UPDATES OVER THE NEXT 7 DAYS
QUARTERLY RESULTS
6 Sept: Kroger, BRP, ABM Industries, Brady, Tsakos Energy, Genesco, Hurco, BeyondSpring, Champions Oncology, Big Lots
9 Sept: Oracle, Rubrik
10 Sept: Petco Health and Wellness, InnovAge Holding, Adriatic Metals
11 Sept: Designer Brands
12 Sept: Adobe, Signet Jewelers
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.